Given the evidence from observational studies in humans demonstrating that MMP-2 levels are positively correlated with LV remodeling early after myocardial infarction and worse HF prognosis [11–17], we would expect that alleles that are less transcriptionally active were associated with decreased risk of developing HF and death. The gene discussed is MMP2; the disease is myocardial infarction.